Please leave a message
Shenzhen B&M Nucleic Acid Extraction Full Scenario Solution

News

Shenzhen B&M Nucleic Acid Extraction Full Scenario Solution

2025-04-30

Our product line offers comprehensive sample volume coverage, catering to diverse research and application needs. For ultra-trace nucleic acid, plasmid extraction, and PCR product purification, we provide 1ml and 2ml processing options. These small-volume solutions are ideal for handling precious samples such as single cells or minute biological specimens where every microliter counts. Moving up the scale, our 4.5ml and 25ml options are designed for medium-scale nucleic acid and plasmid extraction, making them suitable for a wide range of applications from routine laboratory tests to preliminary clinical studies. When dealing with larger volumes, our 36ml, 88ml, and 220ml kits shine. These are specifically engineered for large-scale plasmid and nucleic acid extraction, enabling efficient processing of tissue samples, substantial volumes of body fluids, or industrial-grade biological materials. Whether you are a researcher working on a single-cell genomics project, a clinician analyzing patient samples, or an industrial professional involved in high-throughput production, our diverse volume offerings ensure that you can handle any starting quantity with precision and ease.

图片1.png

     To address the needs of high-throughput projects, we have developed an advanced acceleration platform based on 96-well and 384-well plates. These plates are fully compatible with automated pipetting workstations and nucleic acid extractors, streamlining the sample processing workflow. With this setup, laboratories can process dozens to hundreds of samples in a single batch, significantly reducing the overall experimental cycle. This efficiency boost is invaluable for omics research, where large datasets are essential for drawing meaningful conclusions. For example, in genomics, proteomics, and metabolomics studies, researchers can quickly analyze a vast number of samples to identify genetic variations or biomarker patterns. In the field of pathogen detection, the ability to screen numerous samples rapidly is crucial for public health surveillance and outbreak response. Similarly, in gene分型 (genotyping) projects, which require the analysis of genetic markers across multiple individuals, our high-throughput platform ensures fast and accurate results. By integrating seamlessly with automated systems, it minimizes human error and maximizes productivity, allowing research teams and diagnostic laboratories to execute high-complexity projects with speed and reliability.

Our product stands out with its exceptional performance attributes. We offer two distinct technical routes: the magnetic bead method and the column extraction method. This dual-approach design allows users to select the most suitable technique based on the sample type, whether it is blood, swabs, cells, or animal and plant tissues. Each method has been optimized to deliver consistent, high-quality results, ensuring maximum extraction efficiency and purity. The nucleic acids and plasmids obtained through our processes exhibit high purity levels with minimal inhibitor residues. This characteristic makes them highly compatible with a wide array of downstream molecular biology applications, including PCR amplification, next-generation sequencing, and microarray analysis. By reducing the presence of contaminants, we eliminate potential interference in subsequent experiments, guaranteeing reliable and reproducible data.

图片2.png

Furthermore, our use of pre-dispensed reagents combined with standardized operating procedures significantly reduces manual operation errors. This not only simplifies the experimental process but also enhances the stability and reliability of the results. Whether you are a novice researcher or an experienced professional, our products provide a user-friendly and consistent solution for all your nucleic acid and plasmid extraction needs, ensuring that every experiment yields accurate and trustworthy outcomes.